-
Romiplostim, sold
under the
brand name
Nplate among others, is a
fusion protein analog of thrombopoietin, a
hormone that
regulates platelet production...
-
trials demonstrated romiplostim to be
effective in
treating chronic ITP,
especially in
relapsed post-splenectomy patients.
Romiplostim was
approved by the...
-
antibodies against endogenous thrombopoietin or lead to thrombosis.
Romiplostim (trade name Nplate,
formerly AMG 531) was
found to be safe and effective...
- was
approved by the FDA in
September 2006. 2008: In August,
Nplate (
romiplostim) was
approved by the FDA. 2010: On June 6, 2010,
Amgen received FDA approval...
- inhibitors:
Agerafenib SCF (c-Kit) See here instead.
Thrombopoietin Agonists:
Eltrombopag Pegacaristim Promegapoietin Romiplostim Thrombopoietin (THPO, MGDF)...
- inhibitors:
Agerafenib SCF (c-Kit) See here instead.
Thrombopoietin Agonists:
Eltrombopag Pegacaristim Promegapoietin Romiplostim Thrombopoietin (THPO, MGDF)...
-
selectively targeting effector memory T-cells to
treat psoriasis vulgaris.
Romiplostim: A
peptibody that
treats immune thrombocytopenia. Abatacept/Belatacept:...
-
Thrombopoietin mimetics Abciximab Eptifibatide Tirofiban Others: oprelvekin,
romiplostim, eltrombopag,
argatroban Platelet transfusion is most
frequently used...
-
autoantibodies to
endogenous thrombopoietin and then
developed thrombocytopenia.
Romiplostim and Eltrombopag,
structurally different compounds that
stimulate the...
- inhibitors:
Agerafenib SCF (c-Kit) See here instead.
Thrombopoietin Agonists:
Eltrombopag Pegacaristim Promegapoietin Romiplostim Thrombopoietin (THPO, MGDF)...
